Suchergebnisse - "Esfahani, Ensieh Nasli"

PubPharm (5)

1

Reply to Letter to the Editor "The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes : a randomized, double-blind, placebo-controlled clinical trial"

enthalten in: Acta diabetologica | 2018

von Seyyedebrahimi, S. | Khodabandehloo, H. | Esfahani, E. | +1

CommentOn: Acta Diabetol. 2018 Apr;55(4):341-353. - PMID 29357033

2

Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes : a randomized, double-blind, placebo-controlled study

enthalten in: Nutrition research (New York, N.Y.) | 2018

von Khodabandehloo, H. | Seyyedebrahimi, S. | Esfahani, E. | +2

3

Decreased Serum Level of miR-155 is Associated with Obesity and its Related Metabolic Traits

enthalten in: Clinical laboratory | 2018

von Mahdavi, R. | Ghorbani, S. | Alipoor, B. | +5

4

Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes : A feasibility study

enthalten in: Primary care diabetes | 2016

von Peimani, M. | Rambod, C. | Omidvar, M. | +4

5

Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus

enthalten in: Menopause (New York, N.Y.) | 2016

von Razi, F. | Esmaili, M. | Esfahani, E. | +6

1
[1]